Pfizer, following last year's Chantix recall, pulls blood pressure med in Canada on carcinogen fears

Following last year's wide-ranging Chantix recall, Pfizer is initiating another product pull thanks to higher-than-allowed levels of a likely carcinogen.

Pfizer is pulling 15 lots of its long-acting blood pressure med Inderal from Canadian shelves, citing unacceptable nitrosamine levels across a range of product strengths. The recall specifically covers multiple batches of 60-mg, 80-mg, 120-mg and 160-mg extended-release capsules, the Canadian government said in a recall notice published this week.